European peripheral neuropathy treatment market is estimated to grow at a CAGR of 3.8% during the forecast period. A significant rise in the prevalence of diabetes is resulting in an increasing demand for peripheral neuropathy treatment in the region. As per the International Diabetes Federation (IDF), in 2019, an estimated 59 million adults (20-79 years) had diabetes in the European region. Europe has the largest number of children and adolescents (0-19 years) suffering from type 1 diabetes with 296,500 in 2019. Diabetic peripheral neuropathy ultimately affects approximately 50% of adults suffering from diabetes during their lifetime.
Uncontrolled high blood sugar can damage nerves and impede nerves’ ability to transmit signals, which results in diabetic neuropathy. High blood sugar also impairs the walls of the capillaries (small blood vessels) that deliver the nerves with nutrients and oxygen. Peripheral neuropathy is a common type of diabetic neuropathy, which firstly affects the legs and feet, followed by the arms and hands. The main drugs that are used for neuropathic pain include amitriptyline, duloxetine, gabapentin, and pregabalin.
European peripheral neuropathy treatment market is segmented based on type and application. Based on type, the market is classified into antidepressants, pain relievers, antiseizure, and others. Based on the application, the market is classified into diabetes, chemotherapy-induced, and others. The rising number of new cancer cases has resulted in an increasing demand for chemotherapy to destroy rapidly growing cells in the body. As per the World Health Organization (WHO), in 2018, 4.2 million new cancer incidences were reported in the region. Some chemotherapy drugs that are used for cancer treatment may cause peripheral neuropathy. This is resulting in the demand for peripheral neuropathy treatment in which analgesics, antidepressants, or anticonvulsants, as well as topical numbing agents including lidocaine, are often used for the management of pain. Additionally, opioids may be used in cases that involve extreme pain.
Based on countries, the market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany has been witnessed significant demand for peripheral neuropathy treatment owing to the rising incidences of diabetes in the country. As per the IDF, in 2019, total diabetes cases in adults was 9.5 million. This results in an increasing demand for some antidepressants that are used to ease nerve pain. Tricyclic antidepressants may provide relied on mild to moderate nerve pain. Drugs used for this class include desipramine (Norpramin), imipramine (Tofranil), and amitriptyline.
To Request a Sample of our Report on European Peripheral Neuropathy Treatment Market: https://www.omrglobal.com/request-sample/european-peripheral-neuropathy-treatment-market
European Peripheral Neuropathy Treatment Market-Segmentation
By Type
- Antidepressants
- Pain Relievers
- Antiseizure
- Others
By Application
- Diabetes
- Chemotherapy-Induced
- Others
A full Report of European Peripheral Neuropathy Treatment Market is Available @ https://www.omrglobal.com/industry-reports/european-peripheral-neuropathy-treatment-market
Regional Analysis
- UK
- Germany
- France
- Spain
- Italy
Rest of Europe
Company Profiles
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- GlaxoSmithKline plc
- Grünenthal GmbH
- Hikma Pharmaceuticals Plc
- Mylan N.V.
- Novartis International AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/european-peripheral-neuropathy-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
